logo
Nomad Foods Reports Fourth Quarter and Full Year 2024 Financial Results and Raises Full-Year 2025 Earnings Outlook

Nomad Foods Reports Fourth Quarter and Full Year 2024 Financial Results and Raises Full-Year 2025 Earnings Outlook

Delivered 9th consecutive year of record-high net sales and Adjusted EBITDA
Full year Adjusted EPS of €1.78
Increases full year 2025 Adjusted EPS guidance to €1.85-€1.89
WOKING, England, March 3, 2025 /PRNewswire/ -- Nomad Foods Limited (NYSE: NOMD) (the 'Company' or 'Nomad Foods'), today reported financial results for the three and twelve-month periods ended December 31, 2024.
Nomad Foods delivered strong results in fiscal year 2024, with accelerated organic sales growth driven by higher volumes, while also achieving robust margin expansion and market share gains. The Company maintained its commitment to shareholder returns, distributing €208 million throughout the year in the form of dividends and shares repurchases. Looking ahead to fiscal year 2025, management expects to maintain this momentum with continued top and bottom-line growth. As previously announced, the Board of Directors approved a 13% increase to the company's 1Q25 cash dividend, reflecting continued confidence in the Company's strong cash generation and growth prospects.
Key operating highlights and financial performance for the fourth quarter 2024, when compared to the fourth quarter 2023, include:
Reported revenue increased 4.3% to €793 million
Organic revenue growth of 3.1% with volume growth of 4.7%
Adjusted EBITDA up 17.6% to €137 million
Adjusted EPS rose 31% to €0.42
Key operating highlights and financial performance for the full year 2024, when compared to the full year 2023, include:
Reported revenue increased 1.8% to €3.1 billion
Organic revenue growth of 1.0% with volume growth of 1.3%
Adjusted EBITDA increased 5.6% to €565 million
Adjusted EPS rose 11% to €1.78
Adjusted free cash flow of €292 million, representing an adjusted free cash flow conversation of 101%
2025 full year guidance
For the full year 2025, Nomad Foods continues to expect organic revenue growth of 1%-3% and Adjusted EBITDA growth of 2%-4% while meaningfully increasing investment in its products and brands again in 2025. Adjusted EPS is now expected to be €1.85-€1.89, implying growth of 4-6%, versus the prior outlook of €1.81-€1.85. Based on USD/EUR exchange rate as of February 25, 2025, this translates into 2025 Adjusted EPS of $1.94-$1.98. The Company also continues to expect full year adjusted free cash flow conversion of 90% or greater.
Management & Board Comments
Stéfan Descheemaeker, Nomad Foods' Chief Executive Officer, stated, 'Our 2024 results demonstrate the impact of our focused brand investments and operational excellence, marking our ninth consecutive year of sales and Adjusted EBITDA growth. The investments we began to make in 2023 took hold and delivered strong returns in 2024, as evidenced by our accelerating volume momentum through the final three quarters and market share gains in each of the last two quarters of the year. Growth can be choppy month-to-month and quarter-to-quarter but the underlying trendline of improvement is evident in our results. We significantly strengthened our innovation engine, increasing our innovation as a percent of sales year-over-year, while executing more impactful merchandising programs that resonated with consumers at point-of-sale. Importantly, we accomplished this while expanding margins through a combination of supply chain productivity initiatives and focused growth investments that yielded healthy mix gains. The strength of our execution this year reflects the dedication of our teams and the power of our brands. As we enter 2025, we're confident in our proven strategy and capabilities to deliver what would be our 10th consecutive year of sales and Adjusted EBITDA growth.'
Noam Gottesman, Nomad Foods' Co-Chairman and Founder, commented, 'As we enter our tenth year as a public company, I have never been more optimistic about the growth potential of Nomad Foods. Over the past nine years we have curated a portfolio of iconic brands in an attractive category while building a high-performing team of top-tier talent. Nomad Foods has become a growth advantaged food company as evidenced by its widening top and bottom-line outperformance versus industry peers. We expect this outperformance to continue.'
Fourth Quarter of 2024 results compared to the Fourth Quarter of 2023
Revenue increased 4.3% to €793 million. Organic revenue increase of 3.1% was driven by a 1.6% price/mix decline offset by 4.7% volume growth.
Gross profit increased 9% to €226 million. Gross margin increased 120 basis points to 28.5% due to a positive product mix performance as we invested behind our core most profitable Must Win Battles, and improved supply chain productivity.
Adjusted operating expenses decreased 3% to €114 million due to lower A&P as we cycled a sharp increase in 4Q23 and benefited from a more even investment cadence through 2024.
Adjusted EBITDA increased by 17.6% to €137 million and Adjusted Profit after tax increased 28% to €67 million.
Adjusted EPS increased 31% to €0.42, reflecting the increase in Adjusted Profit after tax and fewer shares outstanding. Reported Diluted EPS increased 113% to €0.32.
Year Ended 2024 results compared to the Year Ended 2023
Revenue increased 1.8% to €3.1 billion. Organic revenue increase of 1.0% was driven by a 0.3% decline in price/mix offset by a 1.3% increase in volume.
Gross profit increased 7% to €918 million. Gross margin increased 140 basis points to 29.6% due to a positive product mix performance as we invested behind our core most profitable Must Win Battles, and improved supply chain productivity.
Adjusted operating expenses increased 7% to €450 million due to increased A&P, and ongoing investments in capabilities development with some inflationary headwinds.
Adjusted EBITDA increased 5.6% to €565 million and Adjusted Profit after tax increased 5% to €289 million,.
Adjusted EPS increased 11% to €1.78, reflecting the increase in Adjusted Profit after tax and fewer shares outstanding. Reported Diluted EPS increased 24% to €1.40.
The company returned €208 million to shareholders in 2024 in the form of dividends and share repurchase activity. The basic shares outstanding at year-end were 156.1 million; a 4% decrease from year-end 2023.
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results today, Monday, March 3, 2025 at 1:30 p.m. GMT (8:30 a.m. Eastern Standard Time). To participate on the live call listeners in North America may dial +1-833-816-1430 and international listeners may dial +1-412-317-0522. Additionally, there will be a presentation to accompany the conference call and the call is being webcast. Both can be accessed at the Nomad Foods website at www.nomadfoods.com under Investor Relations. A replay of the conference call will be available on the Company website for two weeks following the event and can be accessed by listeners in North America by dialing +1-844-512-2921 and by international listeners by dialing +1-412-317-6671; the replay pin number is 10196693.
Investor Relations Contact
Jason English
Media Contact
Elaine McCrimmon, Group Corporate Affairs Director
Nomad Foods (NYSE: NOMD) is Europe's leading frozen food company. The Company's portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers' meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.
Non-IFRS Financial Information
Nomad Foods is presenting Adjusted and Organic financial information, which is considered non-IFRS financial information, for the three and twelve months ended December 31, 2024 and for comparative purposes, the three and twelve months ended December 31, 2023.
Adjusted financial information for the three and twelve months ended December 31, 2024 and 2023 presented in this press release reflects the historical reported financial statements of Nomad Foods, adjusted primarily for share based payment expenses and related employer payroll taxes, non-operating M&A related costs, acquisition purchase price adjustments, exceptional items and foreign currency exchange charges/gains.
Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EPS is defined as diluted earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and twelve months ended December 31, 2024 and 2023 presented in this press release takes into consideration only those activities that were in effect during both time periods. Organic revenue growth/(decline) reflects reported revenue adjusted for currency translation and non-comparable trading items such as expansion, acquisitions, disposals, closures, trading day impacts or any other event that artificially impacts the comparability of our results period over period.
Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities before cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, but after capital expenditure (on property, plant and equipment and intangible assets), net interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives.
Cash flow conversion is Adjusted Free Cash Flow as percentage of Adjusted Profit for the period.
Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of Nomad Foods included in this press release as well as the historical financial statements of the Company previously filed with the SEC.
Nomad Foods believe its non-IFRS financial measures provide an important additional measure with which to monitor and evaluate the Company's ongoing financial results, as well as to reflect its acquisitions. Nomad Foods' calculation of these financial measures may be different from the calculations used by other companies and comparability may therefore be limited. The Adjusted and Organic financial information presented herein is based upon certain assumptions that Nomad Foods believes to be reasonable and is presented for informational purposes only and is not necessarily indicative of any anticipated financial position or future results of operations that the Company will experience. You should not consider the Company's non-IFRS financial measures an alternative or substitute for the Company's reported results and are cautioned not to place undue reliance on these results and information as they may not be representative of our actual or future results as a Company.
Please see on pages 9 to 18, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The Company is unable to reconcile, without unreasonable efforts, Adjusted EPS guidance to the most directly comparable IFRS measure.
Nomad Foods Limited As Reported
Statements of Profit or Loss (unaudited)
Three months ended December 31, 2024 and December 31, 2023
€ in millions
Three months ended
December 31, 2024
Three months ended
December 31, 2023
Revenue
793.4
760.8
Cost of sales
(567.5)
(553.1)
Gross profit
225.9
207.7
Other operating expenses
(115.1)
(122.6)
Exceptional items
(19.3)
(18.4)
Operating profit
91.5
66.7
Finance income
4.4
6.2
Finance costs
(34.6)
(26.7)
Net financing costs
(30.2)
(20.5)
Profit before tax
61.3
46.2
Taxation
(9.9)
(21.5)
Profit for the period
51.4
24.7
Basic earnings per share
Weighted average shares outstanding in millions
158.5
163.8
Basic earnings per share in €
0.32
0.15
Diluted earnings per share
Weighted average shares outstanding in millions
159.2
164.4
Diluted earnings per share in €
0.32
0.15
Statements of Profit or Loss (audited)
Twelve months ended December 31, 2024 and December 31, 2023
€ in millions
Twelve months
ended December 31,
2024
Twelve months
ended December 31,
2023
Revenue
3,099.8
3,044.5
Cost of sales
(2,182.0)
(2,185.8)
Gross profit
917.8
858.7
Other operating expenses
(461.3)
(445.8)
Exceptional items
(69.5)
(72.5)
Operating profit
387.0
340.4
Finance income
30.1
22.8
Finance costs
(139.2)
(109.6)
Net financing costs
(109.1)
(86.8)
Profit before tax
277.9
253.6
Taxation
(50.8)
(60.9)
Profit for the period
227.1
192.7
Basic earnings per share
Weighted average shares outstanding in millions
161.5
170.6
Basic earnings per share in €
1.41
1.13
Diluted earnings per share
Weighted average shares outstanding in millions
162.2
171.2
Diluted earnings per share in €
1.40
1.13
Nomad Foods Limited As Reported
Statements of Financial Position (audited)
As at December 31, 2024 and December 31, 2023
€ in millions
As at December 31, 2024
As at December 31, 2023
Non-current assets
Goodwill
2,106.1
2,105.0
Intangible assets
2,472.9
2,468.2
Property, plant and equipment
591.1
563.7
Other non-current assets
8.6
7.1
Derivative financial instruments
4.3
0.7
Deferred tax assets
14.7
106.9
Total non-current assets
5,197.7
5,251.6
Current assets
Cash and cash equivalents
403.3
412.9
Inventories
441.5
446.4
Trade and other receivables
334.1
263.4
Current tax receivable
37.6
40.7
Indemnification assets
0.5
0.5
Derivative financial instruments
16.9
1.2
Total current assets
1,233.9
1,165.1
Total assets
6,431.6
6,416.7
Current liabilities
Trade and other payables
829.1
769.8
Current tax payable
226.7
189.5
Provisions
27.1
35.1
Loans and borrowings
26.0
21.4
Derivative financial instruments
14.4
12.2
Total current liabilities
1,123.3
1,028.0
Non-current liabilities
Loans and borrowings
2,151.4
2,113.7
Employee benefits
152.1
158.3
Other non-current liabilities
0.5
0.5
Provisions
2.7
1.4
Derivative financial instruments
46.4
97.8
Deferred tax liabilities
292.7
425.1
Total non-current liabilities
2,645.8
2,796.8
Total liabilities
3,769.1
3,824.8
Net assets
2,662.5
2,591.9
Equity attributable to equity holders
Share capital and capital reserve
1,316.4
1,426.1
Share based compensation reserve
26.2
31.4
Translation reserve
135.3
101.0
Other reserves
(14.9)
(24.6)
Retained earnings
1,199.5
1,058.0
Total equity
2,662.5
2,591.9
Nomad Foods Limited As Reported
Statements of Cash Flows (audited)
For the twelve months ended December 31, 2024 and the twelve months ended December 31, 2023
€ in millions
Twelve months ended
December 31, 2024
Twelve months ended
December 31, 2023
Cash flows from operating activities
Profit for the period
227.1
192.7
Adjustments for:
Exceptional items
69.5
72.5
Share based payment expense
8.8
24.1
Depreciation and amortization
96.9
95.0
Loss on disposal and impairment of property, plant and equipment
1.6
1.2
Net finance costs
109.1
86.8
Taxation
50.8
60.9
Operating cash flow before changes in working capital, provisions and
exceptional items
563.8
533.2
(Increase)/decrease in inventories
(1.2)
18.8
(Increase)/decrease in trade and other receivables
(75.0)
0.3
Increase in trade and other payables
68.6
42.1
Decrease in employee benefits and other provisions
(4.0)
(3.2)
Cash generated from operations before tax and exceptional items
552.2
591.2
Payments relating to exceptional items
(72.1)
(67.6)
Receipts relating to exceptional items
4.4

Tax paid
(49.1)
(92.8)
Net cash flows from operating activities
435.4
430.8
Cash flows from investing activities
Purchase of property, plant and equipment and intangibles
(80.3)
(82.4)
Interest received
10.2
5.3
Redemption of investments
5.7
0.3
Cash used in investing activities
(64.4)
(76.8)
Cash flows from financing activities
Repurchase of ordinary shares
(118.7)
(170.9)
Dividends paid
(89.2)

Payments related to shares withheld for tax
(5.8)
(7.1)
Issuance of new loans and notes

6.0
Repayment of loan principal
(6.5)
(12.6)
Payment of lease liabilities
(31.3)
(30.1)
Payment of financing fees
(2.7)
(3.3)
Interest paid
(112.2)
(93.9)
Payment of interest on tax relating to legacy tax audits

(9.2)
Payments on settlement of derivatives

(0.4)
Net cash used in financing activities
(366.4)
(321.5)
Net increase in cash and cash equivalents
4.6
32.5
Cash and cash equivalents at beginning of period
399.7
366.8
Effect of exchange rate fluctuations
(1.0)
0.4
Cash and cash equivalents at end of period(1)
403.3
399.7
(1)
Cash and cash equivalents includes bank overdrafts of nil for the twelve months ended December 31, 2024 ended December 31, 2024 (2023: €13.2 million).
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures
(In € millions, except per share data)
The following table reconciles adjusted financial information for the three months ended December 31, 2024 to the reported results of Nomad Foods for such period.
Adjusted Statement of Profit or Loss (unaudited)
Three months ended December 31, 2024
€ in millions, except per share data
As reported for the
three months ended
December 31, 2024
Adjustments
As adjusted for the
three months ended
December 31, 2024
Revenue
793.4

793.4
Cost of sales
(567.5)

(567.5)
Gross profit
225.9

225.9
Other operating expenses
(115.1)
0.8
(a)
(114.3)
Exceptional items
(19.3)
19.3
(b)

Operating profit
91.5
20.1
111.6
Finance income
4.4

4.4
Finance costs
(34.6)
3.2
(31.4)
Net financing costs
(30.2)
3.2
(c)
(27.0)
Profit before tax
61.3
23.3
84.6
Taxation
(9.9)
(7.6)
(d)
(17.5)
Profit for the period
51.4
15.7
67.1
Weighted average shares outstanding in millions - basic
158.5

158.5
Basic earnings per share in €
0.32
0.42
Weighted average shares outstanding in millions - diluted
159.2

159.2
Diluted earnings per share in €
0.32
0.42
(a)
Share based payment charge including employer payroll taxes of €0.4 million and a non-operating M&A related costs of €0.4 million.
(b)
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) three months ended December 31, 2024' on the next page for a detailed list of exceptional items.
(c)
Elimination of €3.2 million of foreign exchange translation losses.
(d)
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the three months ended December 31, 2024 to the reported results of Nomad Foods for such period.
Adjusted EBITDA (unaudited)
Three months ended December 31, 2024
€ in millions
For the three months
ended December 31,
2024
Profit for the period
51.4
Taxation
9.9
Net financing costs
30.2
Depreciation and amortization
25.5
Exceptional items:
Business Transformation Program
20.8
(a)
Settlement of legacy matters
(1.5)
(b)
Other Adjustments:
Other add-backs
0.8
(c)
Adjusted EBITDA (d)
137.1
(a)
Expenses associated with the multi-year, enterprise-wide transformation and optimization program. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.
(b)
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.
(c)
Represents the elimination of share based payment charge including employer payroll taxes of €0.4 million and elimination of a non-operating M&A related costs of €0.4 million.
(d)
Adjusted EBITDA margin of 17.3% for the three months ended December 31, 2024 is calculated by dividing Adjusted EBITDA by Revenue of €793.4 million.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted financial information for the three months ended December 31, 2023 to the reported results of Nomad Foods for such period.
Adjusted Statements of Profit or Loss (unaudited)
Three months ended December 31, 2023
€ in millions, except per share data
As reported for the three months
ended December 31,
2023
Adjustments
As adjusted for the
three months ended
December 31, 2023
Revenue
760.8

760.8
Cost of sales
(553.1)

(553.1)
Gross profit
207.7

207.7
Other operating expenses
(122.6)
5.3
(a)
(117.3)
Exceptional items
(18.4)
18.4
(b)

Operating profit
66.7
23.7
90.4
Finance income
6.2
(5.2)
1.0
Finance costs
(26.7)
0.4
(26.3)
Net financing costs
(20.5)
(4.8)
(c)
(25.3)
Profit before tax
46.2
18.9
65.1
Taxation
(21.5)
8.7
(d)
(12.8)
Profit for the period
24.7
27.6
52.3
Weighted average shares outstanding in millions - basic
163.8

163.8
Basic earnings per share in €
0.15
0.32
Weighted average shares outstanding in millions - diluted
164.4

164.4
Diluted earnings per share in €
0.15
0.32
(a)
Share based payment charge including employer payroll taxes of €5.1 million and a non-operating M&A related costs of €0.2 million.
(b)
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) three months ended December 31, 2023' on the next page for a detailed list of exceptional items.
(c)
Elimination of €4.9 million of foreign exchange translation gains, €0.3 million of interest income on legacy tax audits and €0.4 million of charges relating to the repricing of debt.
(d)
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the three months ended December 31, 2023 to the reported results of Nomad Foods for such period.
Adjusted EBITDA (unaudited)
Three months ended December 31, 2023
€ in millions
For the three months
ended December 31,
2023
Profit for the period
24.7
Taxation
21.5
Net financing costs
20.5
Depreciation and amortization
26.2
Exceptional items:
Business Transformation Program
16.6
(a)
Fortenova Group integration costs
2.8
(b)
Settlement of legacy matters
(1.0)
(c)
Other Adjustments:
Other add-backs
5.3
(d)
Adjusted EBITDA (e)
116.6
(a)
Expenses associated with the multi-year, enterprise-wide transformation and optimization program. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.
(b)
Expenses associated with the integration of the Fortenova Group acquired on September 30, 2021.
(c)
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.
(d)
Represents the elimination of share based payment charge including employer payroll taxes of €5.1 million and elimination of a non-operating M&A related costs of €0.2 million.
(e)
Adjusted EBITDA margin of 15.3% for the three months ended December 31, 2023 is calculated by dividing Adjusted EBITDA by Revenue of €760.8 million.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the twelve months ended December 31, 2024 to the reported results of Nomad Foods for such period.
Adjusted Statement of Profit or Loss (unaudited)
Twelve months ended December 31, 2024
€ in millions, except per share data
As reported for the
twelve months
ended December 31,
2024
Adjustments
As adjusted for the
twelve months
ended December 31,
2024
Revenue
3,099.8

3,099.8
Cost of sales
(2,182.0)

(2,182.0)
Gross profit
917.8

917.8
Other operating expenses
(461.3)
11.7
(a)
(449.6)
Exceptional items
(69.5)
69.5
(b)

Operating profit
387.0
81.2
468.2
Finance income
30.1
(20.1)
10.0
Finance costs
(139.2)
21.0
(118.2)
Net financing costs
(109.1)
0.9
(c)
(108.2)
Profit before tax
277.9
82.1
360.0
Taxation
(50.8)
(20.4)
(d)
(71.2)
Profit for the period
227.1
61.7
288.8
Weighted average shares outstanding in millions - basic
161.5

161.5
Basic earnings per share in €
1.41
1.79
Weighted average shares outstanding in millions - diluted
162.2

162.2
Diluted earnings per share in €
1.40
1.78
(a)
Share based payment charge including employer payroll taxes of €10.4 million and non-operating M&A related costs of €1.3 million.
(b)
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended December 31, 2024' on the next page for a detailed list of exceptional items.
(c)
Elimination of €14.4 million of net gains on repricing of debt, a €5.7 million gain from the reversal of an impairment loss on a short-term investment, €20.6 million of foreign exchange translation losses and €0.4 million of losses on derivatives.
(d)
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the twelve months ended December 31, 2024 to the reported results of Nomad Foods for such period:
Adjusted EBITDA (unaudited)
Twelve months ended December 31, 2024
€ in millions
For the twelve
months ended
December 31, 2024
Profit for the period
227.1
Taxation
50.8
Net financing costs
109.1
Depreciation and amortization
96.9
Exceptional items:
Business Transformation Program
68.0
(a)
Settlement of legacy matters
1.5
(b)
Other Adjustments:
Other add-backs
11.7
(c)
Adjusted EBITDA (d)
565.1
(a)
Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.
(b)
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.
(c)
Represents the elimination of share based payment charge including employer payroll taxes of €10.4 million and elimination of non-operating M&A related costs of €1.3 million.
(d)
Adjusted EBITDA margin of 18.2% for the twelve months ended December 31, 2024 is calculated by dividing Adjusted EBITDA by Revenue of €3,099.8 million.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted financial information for the twelve months ended December 31, 2023 to the reported results of Nomad Foods for such period.
Adjusted Statements of Profit or Loss (unaudited)
Twelve months ended December 31, 2023
€ in millions, except per share data
As reported for the
twelve months ended
December 31, 2023
Adjustments
As adjusted for the
twelve months ended
December 31, 2023
Revenue
3,044.5

3,044.5
Cost of sales
(2,185.8)

(2,185.8)
Gross profit
858.7

858.7
Other operating expenses
(445.8)
27.1
(a)
(418.7)
Exceptional items
(72.5)
72.5
(b)

Operating profit
340.4
99.6
440.0
Finance income
22.8
(17.0)
5.8
Finance costs
(109.6)
7.5
(102.1)
Net financing costs
(86.8)
(9.5)
(c)
(96.3)
Profit before tax
253.6
90.1
343.7
Taxation
(60.9)
(8.0)
(d)
(68.9)
Profit for the period
192.7
82.1
274.8
Weighted average shares outstanding in millions - basic
170.6

170.6
Basic earnings per share in €
1.13
1.61
Weighted average shares outstanding in millions - diluted
171.2

171.2
Diluted earnings per share in €
1.13
1.61
(a)
Share based payment charge including employer payroll taxes of €26.1 million and non-operating M&A related costs of €1.0 million.
(b)
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended December 31, 2023' on the next page for a detailed list of exceptional items.
(c)
Elimination of €16.7 million of net gains on repricing of debt, €3.5 million of interest cost on tax relating to legacy tax audits, €3.0 million of foreign exchange translation losses, €1.0 million of losses on derivatives and a €0.3 million gain from the reversal of an impairment loss on a short-term investment.
(d)
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles Adjusted EBITDA for the twelve months ended December 31, 2023 to the reported results of Nomad Foods for such period:
Adjusted EBITDA (unaudited)
Twelve months ended December 31, 2023
€ in millions
For the twelve
months ended
December 31, 2023
Profit for the period
192.7
Taxation
60.9
Net financing costs
86.8
Depreciation and amortization
95.0
Exceptional items:
Information Technology Transformation program
0.6
(a)
Business Transformation Program
68.4
(b)
Fortenova Group integration costs
4.3
(c)
Settlement of legacy matters
(0.8)
(d)
Other Adjustments:
Other add-backs
27.1
(e)
Adjusted EBITDA (f)
535.0
(a)
Expenses associated with the Information Technology Transformation program, which are primarily professional fees. The program was completed in 2023.
(b)
Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.
(c)
Expenses associated with the integration of the Fortenova Group acquired on September 30, 2021.
(d)
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.
(e)
Represents the elimination of share based payment charge including employer payroll taxes of €26.1 million and elimination of non-operating M&A related costs of €1.0 million.
(f)
Adjusted EBITDA margin of 17.6% for the twelve months ended December 31, 2023 is calculated by dividing Adjusted EBITDA by Revenue of €3,044.5 million.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
Reconciliation from reported to organic revenue growth/(decline)
The following table is a reconciliation of reported revenue growth to Organic Revenue Growth for the three and twelve month periods ended December 31, 2024.
Year on Year Growth - December 31, 2024 compared with December 31, 2023:
Three months ended
December 31, 2024
Twelve months ended
December 31, 2024
YoY change
YoY change
Reported Revenue Growth
4.3 %
1.8 %
Of which:
Organic Revenue Growth/(Decline)
3.1 %
1.0 %
Translational FX (a)
1.2 %
0.8 %
Total
4.3 %
1.8 %
(a)
Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Nomad Foods Limited
Reconciliation of Non-IFRS Financial Measures (continued)
Reconciliation from reported net cash flows from operating activities to Adjusted free cash flow (unaudited)
The following table is a reconciliation of reported net cash flows from operating activities to Adjusted free cash flow for the twelve months ended December 31, 2024.
Twelve months ended December 31, 2024
€ in millions
Twelve months ended
December 31, 2024
Net cash flows from operating activities
435.4
Add back:
Cash flows relating to exceptional items (a)
67.7
Employer taxes related to share based payments (b)
1.6
Non-operating M&A costs (c)
1.2
Deduct:
Capital expenditure (d)
(80.3)
Net interest paid
(102.0)
Payment of lease liabilities (e)
(31.3)
Adjusted free cash flow
292.3
Adjusted profit for the period
288.8
Adjusted free cash flow as % adjusted profit for the period
101 %
(a)
Adjustment to add back cash flows related to exceptional items which are not considered to be indicative of our ongoing operating cash flows.
(b)
Adjustment to add back working capital movements related to employer taxes related to share based payments which are not considered to be indicative of our ongoing operating cash flows.
(c)
Adjustment to add back cash flows related to non-operating M&A costs which are not considered to be indicative of our ongoing operating cash flows.
(d)
Defined as the sum of property, plant and equipment and intangible assets purchased in the year, which are considered part of the underlying business cash flows.
(e)
These lease liabilities are included in Net Cash Flows from Financing Activities. We believe these payments are part of the underlying business cash flows and should be reflected in Adjusted free cash flow.
Forward-Looking Statements
Forward-Looking Statements and Disclaimers
Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its 2025 guidance with respect to organic revenue growth, Adjusted EBITDA growth, adjusted free cash flow conversion, Adjusted EPS, and Adjusted EPS growth for 2025; (ii) its ability to generate strong top and bottom-line growth and superior shareholder returns; (iii) its cash generation, growth and success in 2025 and beyond; (iv) its ability to outperform its industry peers; and (v) its ability to deliver ten consecutive years of sales and Adjusted EBITDA growth.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in Ukraine and climate-related factors beyond the Company's control; (ii) the Company's ability to successfully mitigate inflationary changes in the market; (iii) the Company's ability to successfully identify suitable acquisition targets and adequately evaluate the potential performance of such acquisition targets; (iv) the Company's ability to successfully implement its strategies (including its M&A strategy) and strategic initiatives and to recognize the anticipated benefits of such strategic initiatives; (v) innovations introduced to the markets and the Company's ability to accurately forecast the brands' performance; (vi) the Company's ability to effectively compete in its markets; (vii) changes in consumer preferences, such as meat substitutes, and the Company's failure to anticipate and respond to such changes or to successfully develop and renovate products; (viii) the effects of reputational damage from unsafe or poor quality food products; (ix) the risk that securities markets will react negatively to actions by the Company; (x) the adequacy of the Company's cash resources to achieve its anticipated growth agenda; (xi) increases in operating costs, including labor costs, and the Company's ability to manage its cost structure; (xii) fluctuations in the availability of food ingredients and packaging materials that the Company uses in its products; (xiii) the Company's ability to protect its brand names and trademarks; (xiv) the Company's ability to prevent, or remediate, any future cybersecurity incidents; (xv) loss of the Company's financial arrangements with respect to receivables factoring; (xvi) the loss of any of the Company's major customers or a decrease in demand for its products; (xvii) economic conditions that may affect the Company's future performance including exchange rate fluctuations; (xviii) the Company's ability to successfully interpret and respond to key industry trends and to realize the expected benefits of its responsive actions; (xix) the Company's failure to comply with, and liabilities related to, environmental, health and safety laws and regulations; (xx) changes in applicable laws or regulations; (xxi) the Company's ability to remediate any material weaknesses in its internal control over financial reporting; and (xxii) the other risks and uncertainties disclosed in the Company's public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company does not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
No Offer or Solicitation
This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.
View original content: https://www.prnewswire.com/news-releases/nomad-foods-reports-fourth-quarter-and-full-year-2024-financial-results-and-raises-full-year-2025-earnings-outlook-302389539.html
SOURCE Nomad Foods Limited
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

Yahoo

time20 minutes ago

  • Yahoo

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for cancer, today announced that an abstract featuring the latest data from a Phase I/II study of the Claudin 18.2 antibody-drug conjugate (ADC), ATG-022, has been accepted for poster presentation at the 2025 European Society for Medical Oncology Annual Congress (ESMO 2025), taking place from October 17th to October 21st at the Messe Berlin in Berlin, Germany. Details of the Poster Presentation: ATG-022 (Claudin 18.2 antibody-drug conjugate)Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH)Abstract Number: 2907Presentation Number: 2113PDate: October 19, 2025 About ATG-022 ATG-022 is an antibody-drug conjugate (ADC) designed to target CLDN18.2, a member of the Claudin family of cell adhesion molecules. Under normal conditions, Claudins are located within tight junctions between cells, forming a barrier to regulate cell permeability. However, in cancer, Claudins are aberrantly expressed on the cell surface due to changes in cell polarity. CLDN18.2 is frequently overexpressed in a range of primary malignant tumors, including gastric, esophageal, cholangiocarcinoma, and pancreatic cancers. The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designations to ATG-022, for gastric and pancreatic cancers. Data from the ongoing CLINCH study demonstrated that ATG-022 delivers robust efficacy across all levels of CLDN18.2 expression in gastric cancer patients, including those with high, low, and ultra-low expression. This broad activity positions ATG-022 as a potential market leader, capable of addressing the largest patient population with CLDN18.2-positive tumors. Furthermore, the strong efficacy observed in patients with low CLDN18.2 expression suggests promise for treating other tumor types with similar expression profiles. About Antengene Antengene Corporation Limited ("Antengene", SEHK: is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of "Treating Patients Beyond Borders". Antengene has built a pipeline of 9 oncology assets at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets, with the NDA for XPOVIO® (selinexor) already approved in Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia. Forward-looking statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company's Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange. For more information, please contact: Investor Contacts: Donald LungE-mail: Mobile: +86 18420672158 PR Contacts:Peter QianE-mail: Mobile: +86 13062747000 View original content to download multimedia: SOURCE Antengene Corporation Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DIVIDEND ALERT! Dow Inc. (DOW) Snaps 3-Day Gains, Falls 17.4%
DIVIDEND ALERT! Dow Inc. (DOW) Snaps 3-Day Gains, Falls 17.4%

Yahoo

time3 hours ago

  • Yahoo

DIVIDEND ALERT! Dow Inc. (DOW) Snaps 3-Day Gains, Falls 17.4%

We recently published . Dow Inc. (NYSE:DOW) is one of the worst-performing stocks on Thursday. Dow Inc. snapped a three-day winning streak on Thursday, dropping 17.45 percent to close at $25.07 apiece as investor sentiment was dampened by a dismal earnings performance in the second quarter of the year. In its earnings release, Dow Inc. (NYSE:DOW) swung to a net loss of $801 million from a $458 million net income in the same period last year. It also posted a six-month net loss of $1.09 billion, reversing a $996 million net income in the same period last year. Net sales similarly declined by 7 percent to $10.1 billion in the second quarter, and by 5 percent to $20.5 billion from $21.68 billion year-on-year. Further dampening sentiment was the company's 50-percent drop in dividend per share, now to 35 cents from 70 cents previously. 'We are aligning the payout size to provide additional financial flexibility. Doing so ensures Dow's ability to prioritize the highest return-generating opportunities, while maintaining a competitive dividend,' said Dow Inc. (NYSE:DOW) Chairman and CEO Jim Fitterling. While we acknowledge the potential of DOW as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio

Tamboran Appoints Board Chairman Dick Stoneburner as Interim CEO
Tamboran Appoints Board Chairman Dick Stoneburner as Interim CEO

Business Wire

time3 hours ago

  • Business Wire

Tamboran Appoints Board Chairman Dick Stoneburner as Interim CEO

NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources Corporation Chairman, Dick Stoneburner, said: 'Tamboran remains committed to completing the tie-in of the five wells on the Shenandoah South 2 pad that are planned to deliver gas into the Sturt Plateau Compression Facility (SPCF) and feed into the 40 MMcf/d Gas Sales Agreement with the Northern Territory Government. We remain focused on unlocking the significant value that we believe the development of the Beetaloo Basin will realize for shareholders and the stakeholders of the Northern Territory. 'Since joining Tamboran as CEO in 2013, Mr. Riddle has overseen the Company's transformation from early-stage natural gas exploration to the brink of commercial production. Under his leadership, Tamboran has pioneered integrated development strategies that combine recognized U.S. shale techniques with Australian operations, driving significant productivity and efficiency gains. 'Additionally, under Joel's leadership, Tamboran successfully acquired and expanded its key assets and operations, resulting in the Company becoming the largest acreage holder and operator in the Beetaloo Basin in the Northern Territory of Australia, with approximately 1.9 million net prospective acres. 'On behalf of the Board, I thank Joel for his dedicated service to Tamboran over the last 12 years and John for his valuable membership on our Board.' Tamboran Resources Corporation Chair of the Nomination and Corporate Governance Committee, Fred Barrett, commented: 'We are also pleased to welcome two deeply experienced executives, Scott and Phillip, to our Board of Directors. They each bring extensive leadership, operational, financial, capital raising, strategic partnering and risk management expertise to Tamboran. 'Their perspectives will be invaluable as we continue to prioritize strategic execution and operational innovation to capitalize on the enormous potential of the Beetaloo Basin. With the appointments of Scott and Phillip, the Board has meaningfully deepened its expertise in large-scale shale development.' The complete cooperation agreement with Sheffield Holdings will be filed on a Current Report on Form 8-K with the U.S. Securities and Exchange Commission. This announcement was approved and authorised for release by Dick Stoneburner, the Chairman of Tamboran Resources Corporation. About Tamboran Resources Corporation Tamboran Resources Corporation ('Tamboran' or the 'Company'), through its subsidiaries, is the largest acreage holder and operator with approximately 1.9 million net prospective acres in the Beetaloo Sub-basin within the Greater McArthur Basin in the Northern Territory of Australia. Tamboran's key assets include a 47.5% operating interest over 20,309 acres in the proposed northern Pilot Area, a 38.75% non-operating interest over 20,309 acres in the proposed southern Pilot Area, a 58.13% operating interest in the proposed Phase 2 development area covering 406,693 acres, a 67.83% operated interest over 219,030 acres in a proposed Retention License 10, a 77.5% operating interest across 1,487,418 acres over ex-EPs 76, 98 and 117, a 100% working interest and operatorship in EP 136 and a 25% non-operated working interest in EP 161, which are all located in the Beetaloo Basin. The Company has also secured ~420 acres (170 hectares) of land at the Middle Arm Sustainable Development Precinct in Darwin, the location of Tamboran's proposed NTLNG project. Pre-FEED activities are being undertaken by Bechtel Corporation. Note on Forward-Looking Statements This press release contains 'forward-looking' statements related to the Company within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements reflect the Company's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words 'believe,' 'expect,' 'anticipate,' 'will,' 'could,' 'would,' 'should,' 'may,' 'plan,' 'estimate,' 'intend,' 'predict,' 'potential,' 'continue,' 'participate,' 'progress,' 'conduct' and the negatives of these words and other similar expressions generally identify forward-looking statements. It is possible that the Company's future financial performance may differ from expectations due to a variety of factors, including but not limited to: our early stage of development with no material revenue expected until 2026 and our limited operating history; the substantial additional capital required for our business plan, which we may be unable to raise on acceptable terms; our strategy to deliver natural gas to the Australian East Coast and select Asian markets being contingent upon constructing additional pipeline capacity, which may not be secured; the absence of proved reserves and the risk that our drilling may not yield natural gas in commercial quantities or quality; the speculative nature of drilling activities, which involve significant costs and may not result in discoveries or additions to our future production or reserves; the challenges associated with importing U.S. practices and technology to the Northern Territory, which could affect our operations and growth due to limited local experience; the critical need for timely access to appropriate equipment and infrastructure, which may impact our market access and business plan execution; the operational complexities and inherent risks of drilling, completions, workover, and hydraulic fracturing operations that could adversely affect our business; the volatility of natural gas prices and its potential adverse effect on our financial condition and operations; the risks of construction delays, cost overruns, and negative effects on our financial and operational performance associated with midstream projects; the potential fundamental impact on our business if our assessments of the Beetaloo are materially inaccurate; the concentration of all our assets and operations in the Beetaloo, making us susceptible to region-specific risks; the substantial doubt raised by our recurring operational losses, negative cash flows, and cumulative net losses about our ability to continue as a going concern; complex laws and regulations that could affect our operational costs and feasibility or lead to significant liabilities; community opposition that could result in costly delays and impede our ability to obtain necessary government approvals; exploration and development activities in the Beetaloo that may lead to legal disputes, operational disruptions, and reputational damage due to native title and heritage issues; the requirement to produce natural gas on a Scope 1 net zero basis upon commencement of commercial production, with internal goals for operational net zero, which may increase our production costs; the increased attention to environmental, social and governance matters and environmental conservation measures that could adversely impact our business operations; risks related to our corporate structure; risks related to our common stock and CDIs; and the other risk factors described more fully in the Company's Annual Report on Form 10-K, which are expressly incorporated herein by reference, and other factors as may periodically be described in the Company's filings with the Securities and Exchange Commission. It is not possible to foresee or identify all such factors. Any forward-looking statements in this release are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future performance and actual results or developments may differ materially from expectations. While the Company continually reviews trends and uncertainties affecting the Company's results of operations and financial condition, the Company does not assume any obligation to update or supplement any particular forward-looking statements contained in this document, except as otherwise required by law. Annexure A About Scott Sheffield Mr. Sheffield has more than 50 years of experience in the energy industry, including building a company into a top tier exploration and production company that was acquired by Exxon Mobil Corporation in a transaction that closed in May 2024. From 2019 until December 31, 2023, he served as a Director and Chief Executive Officer of Pioneer Natural Resources Company ('Pioneer'), a large publicly traded domestic upstream oil and gas company. He retired on December 31, 2023, as CEO and remained as a director until May 2024. Mr. Sheffield served as the founding Chief Executive Officer of Pioneer from August 1997 until his retirement in December 2016, and he also served as Board Chair from 1999 until 2019 when he returned as the CEO. Mr. Sheffield was the CEO of Parker and Parsley Petroleum Company, a predecessor company of Pioneer, from 1985 until it merged with MESA, Inc. to form Pioneer in 1997. Mr. Sheffield joined Parker and Parsley as a petroleum engineer in 1979, was promoted to Vice President of Engineering in 1981, was elected President and a Director in 1985, and became Board Chair and Chief Executive Officer in 1989. Mr. Sheffield served as a Director of Santos Limited, an Australian exploration and production company, from 2014 to 2017. He previously served as a Director from 1996 to 2004 on the Board of Evergreen Resources, Inc., an independent natural gas energy company. Mr. Sheffield holds a Bachelor of Science in Petroleum Engineering from the University of Texas. He has also served on various industry and education-related boards, including the National Petroleum Council, America's Natural Gas Alliance, and the Maguire Energy Institute of the Southern Methodist University Cox School of Business. Mr. Sheffield is also a 2013 inductee to the Permian Basin Petroleum Museum Hall of Fame. About Phillip Pace Phillip Pace has more than 30 years of energy industry experience. From 2017 to 2020 he served as a Director of Lonestar Resources US Inc., a then-publicly traded exploration and production company. From 2009 until his retirement in 2020, Mr. Pace was Founding Partner and Managing Director of Chambers Energy Management, a Houston-based investment firm focused on opportunistic credit investments in the energy industry. He also has extensive experience in energy finance, including 19 years in oil and gas equity research. Following his equity research career, Mr. Pace became Credit Suisse's Head of Exploration and Production Investment Banking in 2005 and Co-Head of Energy Investment Banking in 2006. During his career on Wall Street, Mr. Pace was involved in over $50 billion in completed M&A transactions and over $10 billion in equity capital raised for the exploration and production sector in more than 50 distinct transactions. Mr. Pace holds a Bachelor of Business Administration degree in Finance, with honors, from Texas A&M University and is a Chartered Financial Analyst. He serves on multiple education-related and non-profit boards, including the Yellowstone Academy and Angel Reach.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store